Mark Klang

14 papers receiving 982 citations

Mark Klang's Hit Papers

Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. 2003 · 525 citations
5250+7+15Years since publication100200300400500

Peers

Mark Klang
Comparison fields: 5 of 88
  • Nutrition and Dietetics 312
  • Psychiatry and Mental health 127
  • Molecular Biology 506
  • Oncology 194
  • Physiology 148
Replace Antje Fürstenberg with:
Antje Fürstenberg United Kingdom
E. Aulbert Germany
Karla Sánchez-Lara Mexico
Tetsuo Ikeda Japan
K.C.H. Fearon United Kingdom
Mariann I. Lassenius Finland
Atsushi Uchiyama Japan
R. Laugier France
Mathias Haarhaus Sweden
Elly C. Klinkenberg–Knol Netherlands
Mark Klang relative to Antje Fürstenberg United Kingdom Antje Fürstenberg's profile →
Citations per field
00.5×3.9×
Antje Fürstenberg · 1×
Citations per year

Countries citing papers authored by Mark Klang

Since Specialization
Citations

This map shows the geographic impact of Mark Klang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Klang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Klang more than expected).

Fields of papers citing papers by Mark Klang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Klang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Klang. The network helps show where Mark Klang may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Klang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Klang Line = papers co-authored together Mark Klang links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1
Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
Hit paper breakdown →
2003525
2 2016284
3 201345
4 202243
5 199433
6 201521
7 200218
8
Thiamine status in patients receiving long-term home parenteral nutrition.
199613
9 201012
10 202310
11 20156
12 20234
13
Recommendations for compounding medications for feeding tube administration.
20153
14
Medicating tube-fed patients.
19962
15 20250
16 20230
17 20160
18 20030

About Mark Klang

Mark Klang is a scholar working on Nutrition and Dietetics, Pediatrics, Perinatology and Child Health, Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, having authored 18 papers that have together received 1.0k indexed citations. Recurring topics across this work include Clinical Nutrition and Gastroenterology (8 papers), Pharmaceutical studies and practices (4 papers), Child Nutrition and Feeding Issues (3 papers), Lymphatic System and Diseases (2 papers), Melanoma and MAPK Pathways (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Central Venous Catheters and Hemodialysis (2 papers) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Nutrition and Dietetics (312 citations), Psychiatry and Mental health (127 citations), Molecular Biology (506 citations), Oncology (194 citations) and Physiology (148 citations). Mark Klang has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Marija Drobnjak, Lawrence B. Schwartz, Tracy Curley, Howard I. Scher, Wm. Kevin Kelly, Paul A. Marks, Judy H. Chiao, Richard A. Rifkind, Owen A. O’Connor and Eddie Rosa. Their work appears in journals such as Journal of Parenteral and Enteral Nutrition, Journal of Clinical Oncology, Clinical and Translational Medicine, JCI Insight and JAMA Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact